Ampio Pharm Stock Working Capital
| AMPEDelisted Stock | USD 0.25 0.10 28.57% |
Ampio Pharm fundamentals help investors to digest information that contributes to Ampio Pharm's financial success or failures. It also enables traders to predict the movement of Ampio Pink Sheet. The fundamental analysis module provides a way to measure Ampio Pharm's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ampio Pharm pink sheet.
Ampio |
Ampio Pharm Company Working Capital Analysis
Ampio Pharm's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Ampio Pharm Working Capital | 3.36 M |
Most of Ampio Pharm's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ampio Pharm is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
CompetitionIn accordance with the company's disclosures, Ampio Pharm has a Working Capital of 3.36 M. This is 99.21% lower than that of the Pharmaceuticals sector and 99.38% lower than that of the Health Care industry. The working capital for all United States stocks is 99.77% higher than that of the company.
Ampio Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ampio Pharm's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Ampio Pharm could also be used in its relative valuation, which is a method of valuing Ampio Pharm by comparing valuation metrics of similar companies.Ampio Pharm is currently under evaluation in working capital category among related companies.
Ampio Fundamentals
| Return On Equity | -1.14 | ||||
| Return On Asset | -0.62 | ||||
| Current Valuation | (3.33 M) | ||||
| Shares Outstanding | 1.14 M | ||||
| Shares Owned By Insiders | 1.56 % | ||||
| Shares Owned By Institutions | 4.19 % | ||||
| Number Of Shares Shorted | 32.9 K | ||||
| Price To Earning | 28.57 X | ||||
| Price To Book | 0.21 X | ||||
| EBITDA | (8.63 M) | ||||
| Net Income | (8.63 M) | ||||
| Cash And Equivalents | 23.25 M | ||||
| Cash Per Share | 0.10 X | ||||
| Total Debt | 274 K | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 4.85 X | ||||
| Book Value Per Share | 4.03 X | ||||
| Cash Flow From Operations | (8.56 M) | ||||
| Short Ratio | 0.31 X | ||||
| Earnings Per Share | (10.66) X | ||||
| Target Price | 2.0 | ||||
| Beta | 1.95 | ||||
| Market Capitalization | 340.61 K | ||||
| Total Asset | 5.74 M | ||||
| Retained Earnings | (242.53 M) | ||||
| Working Capital | 3.36 M | ||||
| Current Asset | 29.23 M | ||||
| Current Liabilities | 5.52 M | ||||
| Net Asset | 5.74 M |
About Ampio Pharm Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ampio Pharm's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ampio Pharm using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ampio Pharm based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Ampio Pharm
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ampio Pharm position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ampio Pharm will appreciate offsetting losses from the drop in the long position's value.Moving together with Ampio Pink Sheet
| 0.74 | DMAC | DiaMedica Therapeutics Earnings Call This Week | PairCorr |
Moving against Ampio Pink Sheet
| 0.88 | VERU | Veru Inc Financial Report 9th of May 2024 | PairCorr |
| 0.57 | DOMH | Dominari Holdings Earnings Call This Week | PairCorr |
| 0.56 | YS | YS Biopharma | PairCorr |
The ability to find closely correlated positions to Ampio Pharm could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ampio Pharm when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ampio Pharm - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ampio Pharm to buy it.
The correlation of Ampio Pharm is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ampio Pharm moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ampio Pharm moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ampio Pharm can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Consideration for investing in Ampio Pink Sheet
If you are still planning to invest in Ampio Pharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ampio Pharm's history and understand the potential risks before investing.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |